View of 1096 – Oncological safety of sentinel lymph node biopsy with single mapping tracer in cN+/ypN0 breast cancer women post-neoadjuvant chemotherapy: a real-world data study

Return to Article Details 1096 – Oncological safety of sentinel lymph node biopsy with single mapping tracer in cN+/ypN0 breast cancer women post-neoadjuvant chemotherapy: a real-world data study Download Download PDF